Isatuximab is a chimeric IgG1-kappa anti-CD38 monoclonal antibody which selectively binds to a unique epitope on human CD38 receptor and elicits anti-MM activity by direct apoptosis, ADCC, and ADCP [47]. Here, CD38 is linked to Miyoshi myopathy.